Autologous Cell Therapy Engineer Intern - Gaithersburg, MD jobs in United States
cer-icon
Apply on Employer Site
company-logo

AstraZeneca · 1 day ago

Autologous Cell Therapy Engineer Intern - Gaithersburg, MD

AstraZeneca is seeking undergraduate sophomore and junior level students for a 12-week internship role in Gaithersburg, MD. The role involves process mapping, data analysis, and workflow optimization to support autologous cell therapy initiatives.

BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
check
Comp. & Benefits
badNo H1Bnote

Responsibilities

Process mapping and documentation: Create process flow diagrams, SOPs, and batch records; define critical parameters, in‑process controls, and standardized handoffs
Process data analysis: Execute small-scale experiments (e.g., DoE) on key equipment; analyze yield, viability, and phenotype to set parameter ranges and control strategies
Workflow optimization: Support streamline material/operator flows to improve efficiency and reduce COGS

Qualification

Wet lab skillsData visualization/analysisExcelPowerPointPythonSQLJMPCommunicationCollaboration

Required

Undergraduate sophomore and junior level students majoring in Bioengineering, Biomedical Engineering, Chemical Engineering, Biology or a related discipline
Candidates must have an expected graduation date after August 2026
Wet lab skills such as aseptic cell cultures and micro pipetting are required
Ability to report onsite to Gaithersburg, MD 4-5 days per week
US Work Authorization is required at time of application
This role will not be providing CPT support

Preferred

Software exposure to Excel and PowerPoint
Soft skills like communication and collaboration
Data visualization/analysis skills such as Python, SQL or JMP

Company

AstraZeneca

company-logo
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.

Funding

Current Stage
Public Company
Total Funding
$5.26B
2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B

Leadership Team

leader-logo
Pascal Soriot
Chief Executive Officer
leader-logo
Aradhana Sarin
Group CFO and Executive Director
linkedin
Company data provided by crunchbase